Growth Accelerated By Rising Prevalence Of Chronic And Orphan Diseases

Medical foods are specially formulated and processed products designed to manage chronic diseases and orphan diseases. They are indicated for the dietary management of patients with impaired gastrointestinal tracts or metabolic or inherited disorder diseases. The rising prevalence of chronic diseases, such as diabetes, cancer, cardiovascular diseases, and neurological diseases, is expected to boost the demand for medical foods over the forecast period.

The global U.S. Medical Foods Market is estimated to be valued at US$ 25722.45 Bn in 2024 and is expected to exhibit a CAGR of 21.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing prevalence of orphan diseases is one of the major factors driving the growth of the U.S. medical foods market. According to the Office of Orphan Products Development of the FDA, a disease or condition is considered rare in the United States if it affects fewer than 200,000 people. Medical foods help support the management of food-responsive metabolic abnormalities associated with orphan diseases for which specific nutritional requirements have been established. Many companies are focusing on developing orphan disease-specific medical foods to address the unmet needs in this market. This is expected to boost the demand for medical foods over the forecast period.

Segment Analysis

The U.S. medical foods market is dominated by the metabolic disorder sub segment. Around 70% of the total medical foods products sold in the market falls under this category. Medical foods for metabolic disorders like phenylketonuria (PKU), homocystinuria, maple syrup urine disease (MSUD) forms the bulk of demand in this space. These are lifelong conditions requiring constant monitoring and management of dietary needs. Patient adherence to prescribed medical food regimens is high in this segment.

Key Takeaways

The Global U.S. Medical Foods Market Demand is expected to witness high growth over the forecast period of 2024 to 2031.

Regional analysis showed that the Western region holds the major share in the U.S. medical foods market currently. States like California, Washington and Colorado have witnessed highest demand and sales of various medical food products over the last few years due to growing health awareness and healthcare expenditure.

Key players operating in the U.S. medical foods market are Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.

Explore more information on this topic, Please visit-
https://www.insightprobing.com/u-s-medical-foods-market-growth-and-trnds-analysis-share-size-demand-forecast/